Concepedia

Author

Michael Haude

Essen University HospitalORCID

Also Known As

H. Nef, Haude, M, Joerg Haasenritter, Luca Testa, M HAUDE, M Haude, M. HAUDE, M. Haude, MICHAEL HAUDE, MICHAEL. HAUDE

473

Publications

22.9K

Citations

66

H-Index

77

Concepts

All Affiliations

Essen University HospitalLukaskrankenhausJohannes Gutenberg University MainzMedStar Washington Hospital CenterUniversity of Duisburg-Essen
MH

About

Michael Haude is an author at Essen University Hospital specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

65

6.6K

2

Engineering

10

10

966

3

Health Sciences

5

5

143

4

Education

1

1

46

5

Law

1

1

104

Michael Haude

×

154

Publications

13.6K

Citations

60

H-Index

YearCitations

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

Raimund Erbel, Carlo Di Mario, Jozef Bartúnek,

The Lancet

2007

895

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek,

The Lancet

2014

556

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi,

The Lancet

2016

534

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Michael Haude, Raimund Erbel, Paul Erné,

The Lancet

2013

419

High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P <sub>3</sub> Lysophospholipid Receptor

Gregor Theilmeier, Christoph Schmidt, Jörg Herrmann,

Circulation

2006

411

Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation

Joachim Schöfer, Tomasz Siminiak, Michael Haude,

Circulation

2009

363

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

Michael Haude, Hüseyin İnce, Alexandre Abizaid,

The Lancet

2015

347

A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial

Alexandra J. Lansky, Joachim Schöfer, Didier Tchétché,

European Heart Journal

2015

298

Comparison of Electron Beam Computed Tomography With Intracoronary Ultrasound and Coronary Angiography for Detection of Coronary Atherosclerosis

Dietrich Baumgart, Axel Schmermund, Guenter Goerge,

Journal of the American College of Cardiology

1997

297

Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty

Raimund Erbel, Michael Haude, Hans W. Höpp,

New England Journal of Medicine

1998

295

Page 1